Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00761176 · ClinicalTrials.gov registry record · NA
A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
A NA study, sponsored by Regenesis Biomedical.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00761176 is a NA study that was terminated before completion, run by Regenesis Biomedical. The registered enrollment target is 8 participants.
The verdict
NCT00761176, a NA study, was terminated before completion, sponsored by Regenesis Biomedical.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this study is to compare the reduction in wound surface areas between patients with diabetic ulcers utilizing Provant's pulsed radio frequency energy therapy (PRFE) as an adjunct to standardized basic wound care to those utilizing standardized basic wound care alone.
Interventions
- DEVICE The Provant Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00761176
The ClinicalTrials.gov registry entry for NCT00761176 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenesis Biomedical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Provant Therapy System is the first listed.
NCT00761176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00761176 about?
NCT00761176 is a clinical study titled "A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers". The objective of this study is to compare the reduction in wound surface areas between patients with diabetic ulcers utilizing Provant's pulsed radio frequency energy therapy (PRFE) as an adjunct to standardized basic wound care to those utilizing standardized basic wound care alone.
What is the current status of trial NCT00761176?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00761176?
The interventions under investigation include: The Provant Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00761176?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.